Examkin

Patient Management

2074 questions

All types2,074Multiple choice1,048Multiple select393Matching221Ordering412
Question 1521Question →

A 42-year-old man is evaluated for discharge planning. Eight weeks ago, he was involved in a high-speed motorcycle collision resulting in a T6 spinal cord transection and complete paraplegia. During his initial prolonged intensive care stay, his course was complicated by a severe stage 4 sacral pressure injury. Ten days ago, he underwent surgical debridement and closure of the ulcer with a gluteal musculocutaneous flap.

His postoperative course has been uncomplicated. The surgical drains were removed yesterday, and the incision is clean, dry, and intact. He is hemodynamically stable, afebrile, and his medications have been transitioned from intravenous to oral routes.

On physical examination, upper extremity strength is 5/5 bilaterally, but he has no sensory or motor function below the T6 level. Per the plastic surgery protocol, he must remain on strict bed rest in prone or alternating lateral decubitus positions for the next 4 weeks to ensure flap viability. He requires assistance from two staff members to turn every 2 hours and must avoid any sitting, shearing forces, or supine positioning. Physical and occupational therapy note that due to these severe positional restrictions, he can currently tolerate a maximum of 45 minutes of recumbent upper-body therapeutic exercise daily. Prior to his injury, he lived alone in a second-floor walk-up apartment.

Which of the following is the most appropriate disposition for this patient at this time?

Show answer & explanation

Answer: Skilled nursing facility

Answer

The correct disposition is transfer to a skilled nursing facility.
The patient requires daily skilled nursing care to manage complex wound protocols and provide specialized, two-person positional turning every 2 hours to ensure the survival of his gluteal flap. However, he is medically stable (ruling out LTACH or continued acute care) and his strict bed rest restrictions limit his therapy tolerance to 45 minutes daily. Because he cannot meet the strict Centers for Medicare & Medicaid Services (CMS) requirement of tolerating 3 hours of intensive therapy per day, he cannot go to an Inpatient Rehabilitation Facility (IRF). A Skilled Nursing Facility (SNF) is the correct disposition to provide the necessary 24-hour skilled nursing care while he recovers enough to potentially transition to an IRF in the future.

Step-by-Step Solution

1
Assess the patient's medical and surgical stability.
The patient is hemodynamically stable, off intravenous medications, and the surgical drains have been removed. He no longer requires acute hospital-level care.
This rules out continued acute hospital stay or transition to a long-term acute care hospital (LTACH).
2
Evaluate the patient's ability to participate in rehabilitation.
The patient is on strict bed rest and can only tolerate 45 minutes of recumbent therapy per day.
Admission to an Inpatient Rehabilitation Facility (IRF) mandates that a patient can tolerate and actively participate in at least 3 hours of intensive therapy per day (or 15 hours per week). The patient's surgical restrictions contraindicate an IRF admission at this time.
3
Determine the required level of daily care based on surgical protocols and social determinants.
The patient requires Q2H turning by two people, specialized flap monitoring, and lives alone in an inaccessible apartment.
This establishes that home discharge is unsafe and unfeasible, and that he requires 24-hour skilled nursing care, making a Skilled Nursing Facility (SNF) the only appropriate disposition.

Key Concept

Selecting the appropriate post-acute care facility requires matching a patient's medical acuity, nursing needs, and rehabilitation tolerance. Inpatient Rehabilitation Facilities (IRF) require patients to tolerate at least 3 hours of daily therapy, while Skilled Nursing Facilities (SNF) bridge the gap for patients needing daily skilled care (like complex wound protocols) who cannot meet IRF therapy requirements.
Question 1522Question →

A 60-year-old man with metastatic pancreatic cancer is hospitalized for management of intractable abdominal pain and jaundice. He has a biliary stent placement scheduled for the next day. However, during morning rounds, the patient states that he no longer wants the procedure or any further medical interventions, including his current intravenous antibiotics for ascending cholangitis. He clearly expresses that he understands the risks of stopping treatment, including overwhelming sepsis and imminent death. He states, "I am exhausted and ready to let nature take its course." The patient's adult daughter, who is designated as his healthcare proxy in his advance directive, insists that the medical team proceed with the stent placement and antibiotics, arguing that the patient's pain medications are clouding his judgment. The patient is alert, oriented to person, place, time, and situation, and can clearly articulate the reasoning behind his decision. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Honor the patient's refusal of treatment and initiate a transition to comfort care

Answer

Honor the patient's refusal of treatment and initiate a transition to comfort care.
The correct answer correctly identifies that a patient who possesses clinical decision-making capacity has the absolute right to refuse any medical treatment, including life-sustaining interventions. Decision-making capacity requires the patient to understand their condition, the proposed treatments, the alternatives, and the consequences of their decision. This patient demonstrates intact capacity by clearly articulating his understanding that refusing the stent and antibiotics will lead to sepsis and death. Therefore, his informed refusal must be honored, and care should be transitioned to comfort measures according to his wishes.

Step-by-Step Solution

1
Assess the patient's clinical decision-making capacity.
The patient is alert, oriented, and clearly articulates an understanding of the risks and consequences of refusing treatment.
Capacity is the primary requirement for a patient to autonomously refuse life-saving medical interventions.
2
Evaluate the role of the healthcare proxy in the current context.
The proxy's authority is not activated because the patient retains his own decision-making capacity.
A designated healthcare proxy only has decision-making authority when the patient becomes incapacitated.
3
Determine the appropriate management plan based on ethical principles.
The patient's informed refusal must be honored, and the focus of care shifts to palliative and comfort measures.
Competent adults have the legal and ethical right to refuse any medical treatment, even if that refusal leads to imminent death.

Key Concept

Patients with intact clinical decision-making capacity have the right to refuse life-sustaining interventions, and this supersedes the wishes of a designated healthcare proxy.
Question 1523Question →

Match each complex end-of-life clinical scenario with the most appropriate ethical principle or legal determination governing its management.

Click a left item, then click its matching right item

Items

An incapacitated adult patient lacks an advance directive. A disagreement arises regarding code status between the patient's cohabitating unmarried partner of fifteen years and the patient's estranged adult biological child.
A capacitated patient with terminal pancreatic cancer requests that the attending physician directly administer a lethal dose of intravenous potassium chloride to end their suffering.
A designated healthcare proxy demands surgical placement of a feeding tube for a patient with end-stage dementia, an intervention the medical team has determined will cause physiological harm without clinical benefit.
A legally appointed conservator demands initiation of mechanical ventilation for an incapacitated patient, directly contradicting the patient's applicable and valid living will refusing such interventions.

Matches

Show answer & explanation

Answer

Proper end-of-life care requires strict adherence to legal surrogate hierarchies, absolute prohibition of active euthanasia, the right to refuse harmful non-beneficial treatments, and the absolute precedence of documented autonomous wishes.
The correct matches align specific end-of-life conflicts with their governing legal and ethical principles. Surrogate hierarchies strictly favor blood relatives absent a written proxy; active euthanasia is universally illegal; non-maleficence allows the refusal of harmful medical treatments; and written advance directives legally override contradictory surrogate demands.

Step-by-Step Solution

1
Analyze the surrogate hierarchy conflict between the unmarried partner and the estranged child.
The estranged adult child takes precedence over the unmarried partner.
State laws dictate a strict default hierarchy (spouse, adult children, parents, siblings) when no proxy is designated; unmarried partners are legally excluded or placed lower in priority regardless of relationship duration.
2
Evaluate the patient's request for physician-administered lethal medication.
The request must be denied as it describes active euthanasia.
While Medical Aid in Dying (MAID) is legal in some states, direct administration of a lethal agent by a physician (active euthanasia) remains a felony nationwide.
3
Assess the ethical obligation regarding the proxy's demand for a harmful feeding tube in advanced dementia.
The medical team can ethically refuse the intervention.
The principle of non-maleficence allows physicians to withhold interventions that offer no physiological benefit and induce suffering, even if fiercely demanded by a legal proxy.
4
Determine legal precedence between a previously executed living will and a conservator's present demands.
The living will dictates the plan of care.
Written advance directives are the strongest expression of patient autonomy and supersede the authority of any surrogate decision-maker, including court-appointed guardians.

Key Concept

Resolution of ethical and legal conflicts in end-of-life care planning
Question 1524Question →

A psychiatrist is evaluating several patients in the psychiatric emergency department and outpatient clinic to determine the appropriate level of care. Match each patient's clinical presentation and psychosocial status with the most appropriate behavioral health disposition.

Click a left item, then click its matching right item

Items

A 24-year-old man with acute psychosis experiencing command hallucinations to harm his neighbors, who lacks insight and refuses treatment.
A 42-year-old woman with severe major depressive disorder who is safe at home overnight with her spouse but requires 5 days per week of 6-hour structured clinical therapy to prevent inpatient admission.
A 30-year-old woman with a history of substance use disorder, currently abstinent but struggling with cravings, who is working part-time and needs 9 hours of therapy per week.
A 68-year-old man with chronic schizophrenia whose symptoms are at baseline, but who recently lost his housing and requires long-term daily supervision for medication administration and meals.

Matches

Show answer & explanation

Answer

The correct matches align each patient's acuity, safety risk, and functional need with the corresponding psychiatric care setting: involuntary admission for acute risk to others, PHP for intensive daytime treatment, IOP for moderate treatment allowing work, and a residential facility for chronic supervision needs.
The correct matches pair the intensity of the care setting directly with the patient's acuity and psychosocial resources. Imminent danger to others mandates an involuntary inpatient unit. High-acuity symptoms needing daily structure but without overnight risk map to PHP. Moderate symptoms allowing for functional responsibilities map to IOP. Stable symptoms lacking psychosocial independence map to residential facilities.

Step-by-Step Solution

1
Assess the safety risk and acuity of the 24-year-old man.
He has command hallucinations to harm others and refuses voluntary care.
Imminent danger to others requires a secure, involuntary setting.
2
Determine the level of structured therapy required for the 42-year-old woman.
She needs daily 6-hour therapy to prevent hospitalization but is safe overnight.
This specific high-intensity daytime requirement meets the criteria for a partial hospitalization program (PHP).
3
Evaluate the scheduling needs and acuity of the 30-year-old woman.
She requires moderate support while maintaining part-time employment.
Intensive outpatient programs (IOP) provide 9 to 15 hours of weekly therapy, allowing for community integration.
4
Identify the chronic needs of the 68-year-old man.
He is at his psychiatric baseline but lacks housing and requires medication supervision.
Stable patients needing daily living support require residential facilities, not acute psychiatric interventions.

Key Concept

Psychiatric disposition requires matching the patient's immediate safety risk, symptom acuity, and functional capacity to the least restrictive environment that can safely manage their therapeutic and basic living needs.
Question 1525Question →

During a busy afternoon in an outpatient internal medicine clinic, a physician encounters four patients who report non-adherence to their prescribed medical therapies for various reasons. Match each patient's statement regarding their specific barrier to adherence with the most appropriate, targeted physician counseling response.

Click a left item, then click its matching right item

Items

I stopped taking my hypertension medication because I feel perfectly healthy and do not have any symptoms.
I read on an internet forum that this statin causes permanent muscle damage, so I threw the bottle away.
I take my morning dose consistently, but I almost always forget to take my evening pill after work.
I wanted to pick up the inhaler you prescribed, but the pharmacy informed me the out-of-pocket cost is $200 per month.

Matches

Show answer & explanation

Answer

Match the lack of perceived need to eliciting disease understanding; match the fear of misinformation to evidence-based reassurance; match forgetfulness to practical behavioral cues; and match the financial barrier to social work and systemic resources.
Matching each adherence barrier to its targeted intervention ensures effective, patient-centered care. Addressing asymptomatic disease requires education, fear requires validation and clinical data, forgetfulness requires behavioral cues, and cost requires systemic resources.

Step-by-Step Solution

1
Analyze the first statement regarding feeling healthy without the medication.
Identifies a lack of perceived need due to an asymptomatic disease process (hypertension).
Guides the physician to prioritize disease-state education over logistical interventions.
2
Evaluate the statement about internet reports of permanent muscle damage.
Identifies fear of adverse effects driven by external misinformation.
Requires validation of the patient's anxiety followed by targeted, evidence-based education.
3
Assess the statement regarding missing the evening dose.
Identifies practical forgetfulness as the primary barrier.
Prompts the recommendation of behavioral cueing and adherence aids rather than further medical education.
4
Review the statement about the high out-of-pocket cost.
Identifies a definitive financial barrier to medication access.
Necessitates system-level problem solving, such as a social work referral, rather than motivational interviewing.

Key Concept

Tailoring physician counseling and interventions to specific medication adherence barriers.
Question 1526Question →

During an interdisciplinary family meeting in the intensive care unit regarding a transition to comfort measures, the attending physician navigates a highly charged emotional environment. To foster therapeutic alignment and respond to emotional cues effectively, the physician employs the NURSE framework. Match each physician statement used during the encounter to the specific empathetic communication technique it best represents.

Click a left item, then click its matching right item

Items

"It makes complete sense that you are frustrated given the unexpected delays in getting the biopsy results."
"I wonder if you might be feeling terrified about what these next few weeks will look like for your family."
"Could you tell me a bit more about what your mother's independence meant to her before she became ill?"
"Our palliative care team will be here with you every single day to ensure she remains completely comfortable."
"You have done an extraordinary job advocating for her wishes and managing her complex care at home."

Matches

Show answer & explanation

Answer

Statement 1 matches Understanding (Legitimation). Statement 2 matches Naming the emotion. Statement 3 matches Exploring. Statement 4 matches Supporting (Partnership). Statement 5 matches Respecting (Praising).
The correct pairings directly reflect the definitions of the NURSE mnemonic for empathetic communication. Naming involves explicitly stating the emotion. Understanding (Legitimation) validates the emotion as normal. Respecting praises the patient's efforts. Supporting demonstrates ongoing commitment. Exploring invites further elaboration.

Step-by-Step Solution

1
Analyze the first statement regarding frustration and delays.
The physician is validating the emotion by saying 'it makes complete sense'.
Validation of an emotion as a normal response corresponds to the 'Understanding' or 'Legitimation' step of the NURSE protocol.
2
Analyze the statement explicitly bringing up the feeling of being 'terrified'.
The physician is suggesting a label for the family's unstated emotion.
Vocalizing the emotion explicitly is the 'Naming' component of the framework.
3
Analyze the statement praising the family's advocacy.
The physician is explicitly highlighting the family's positive contributions.
Acknowledging the patient's or family's efforts aligns with the 'Respecting' component.
4
Analyze the statement promising daily check-ins.
The physician is demonstrating a commitment to non-abandonment.
Pledging ongoing partnership and care aligns with the 'Supporting' component.
5
Analyze the prompt asking to 'tell me a bit more'.
The physician is asking an open-ended question to gather more emotional context.
Inviting elaboration is the 'Exploring' component of the framework.

Key Concept

The NURSE framework (Naming, Understanding, Respecting, Supporting, Exploring) is a validated communication tool used to respond to patient and family emotions effectively.
Estimated Time:1m 30s
Question 1527Question →

A 48-year-old woman is newly diagnosed with moderate, seropositive rheumatoid arthritis. Her physician decides to initiate disease-modifying therapy with oral methotrexate along with daily folic acid supplementation. Her past medical history is otherwise unremarkable, and baseline laboratory investigations are within normal limits. Which of the following parameters are essential to monitor routinely to detect common adverse effects of this pharmacological therapy? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Complete blood count; Hepatic aminotransferases

Answer

The essential parameters to monitor routinely in this patient are a complete blood count and hepatic aminotransferases.
Methotrexate is an antimetabolite that acts by inhibiting dihydrofolate reductase. Its most common and potentially severe adverse effects include bone marrow suppression (which can present as macrocytic anemia, leukopenia, or thrombocytopenia) and hepatotoxicity. Therefore, standard of care requires routine monitoring with a complete blood count and liver function tests (including hepatic aminotransferases) at baseline and periodically throughout the duration of treatment.

Step-by-Step Solution

1
Identify the prescribed medication and its established side effect profile.
The medication is methotrexate, an antimetabolite whose major toxicities include myelosuppression, hepatotoxicity, and pulmonary toxicity.
Understanding the drug's specific toxicity profile dictates the appropriate clinical monitoring strategy.
2
Select the laboratory tests that correspond directly to the identified risks.
A complete blood count is necessary to monitor for bone marrow suppression, and hepatic aminotransferases are necessary to monitor for hepatotoxicity.
Routine surveillance with these specific tests allows for early detection of adverse effects before they become clinically severe or irreversible.

Key Concept

Routine monitoring for methotrexate therapy requires regular assessment of a complete blood count, liver function tests (including aminotransferases), and renal function due to the risks of myelosuppression, hepatotoxicity, and delayed renal clearance.
Estimated Time:45s
Question 1528Question →

A hospitalist is planning the transition of care for an 81-year-old female patient on hospital day 9. She was initially admitted to the intensive care unit for septic shock secondary to acute pyelonephritis and required vasopressor support for 48 hours. She has been on the general medical floor for the past 5 days and is now hemodynamically stable. Intravenous antibiotics have been transitioned to oral therapy. Her serum creatinine has improved from a peak of 2.8 mg/dL2.8 \text{ mg/dL} to 1.3 mg/dL1.3 \text{ mg/dL} (baseline 1.0 mg/dL1.0 \text{ mg/dL}). Her white blood cell count is 9,500/μL9,500/\mu\text{L}.

Prior to her illness, the patient lived alone in an apartment and managed her own instrumental activities of daily living. Currently, she is alert, oriented, and cognitively intact. However, she exhibits profound generalized weakness. Physical and occupational therapy evaluations note that she requires moderate assistance to transfer from bed to chair and can ambulate only 15 feet with a wheeled walker. She actively participates in therapy but becomes severely fatigued after 45 to 60 minutes of total daily exertion. She requires assistance with bathing and dressing. Her son lives nearby but is unable to provide daytime care.

Which of the following is the most appropriate care setting for this patient's disposition?

Show answer & explanation

Answer: Skilled nursing facility

Answer

Skilled nursing facility
The correct answer is a skilled nursing facility (SNF). This patient is medically stable and has significant rehabilitation potential to return to her baseline of independent living. However, she currently requires daily skilled therapy and moderate assistance for transfers. While she needs intensive rehabilitation, her fatigue after 45 to 60 minutes disqualifies her from an acute inpatient rehabilitation facility (IRF), which requires patients to tolerate at least 3 hours of therapy per day. An SNF provides the appropriate level of daily skilled physical and occupational therapy at a pace she can tolerate, alongside 24-hour nursing support.

Step-by-Step Solution

1
Assess the patient's current medical stability.
The patient is hemodynamically stable, off vasopressors, taking oral antibiotics, and has improving renal function.
To rule out the need for ongoing acute care or long-term acute care (LTACH).
2
Evaluate the patient's baseline function and rehabilitation potential.
The patient lived independently before admission and actively participates in therapy, indicating high rehabilitation potential.
To rule out custodial care, which does not provide daily skilled rehabilitation for recovery.
3
Determine the patient's functional tolerance for rehabilitation.
She severely fatigues after 45 to 60 minutes of exertion.
To determine eligibility for an acute inpatient rehabilitation facility (IRF), which strictly requires tolerance of at least 3 hours of therapy per day.
4
Analyze social support for potential home discharge.
She lives alone, needs moderate assistance for transfers, and lacks daytime support from her son.
To confirm that discharge to home with intermittent home health services is unsafe.
5
Synthesize the data to select the most appropriate care setting.
Skilled nursing facility (SNF)
An SNF provides the required daily skilled therapy at a tolerable pace (1-2 hours/day) with 24-hour nursing support, ensuring safety and optimal recovery.

Key Concept

Patients who are medically stable and require daily skilled rehabilitation, but cannot tolerate the 3-hour daily therapy requirement of an acute inpatient rehabilitation facility (IRF), should be discharged to a skilled nursing facility (SNF).
Question 1529Question →

A primary care physician is managing a full schedule of adult patients presenting for routine health evaluations. Assign the single most appropriate, guideline-based preventive screening intervention to each patient based on their distinct demographic and risk profile.

Click a left item, then click its matching right item

Items

Male patient, age 65, who accumulated a 35-pack-year smoking history before quitting at age 50.
Female patient, age 55, currently smoking one and a half packs of cigarettes daily for the past 20 years.
Female patient, age 24, who is sexually active and has no active symptoms.
Female patient, age 65, attending a standard evaluation with no prior bone density testing.

Matches

Show answer & explanation

Answer

The 65-year-old male former smoker requires a one-time abdominal ultrasound. The 55-year-old female current smoker requires annual low-dose chest computed tomography. The 24-year-old female requires cervical cytology every 3 years. The 65-year-old female with no prior fracture assessment requires a dual-energy x-ray absorptiometry (DXA) scan.
Each patient profile unequivocally meets the demographic and clinical criteria for a distinct, high-priority screening modality. The 65-year-old male with a smoking history requires an ultrasound for AAA. The 55-year-old with a 30 pack-year current smoking history requires a low-dose CT for lung cancer. The 24-year-old requires a Pap smear for cervical cancer. The 65-year-old woman requires a DXA scan for osteoporosis.

Step-by-Step Solution

1
Evaluate the 65-year-old male with a history of smoking.
Identify indication for Abdominal Aortic Aneurysm (AAA) screening.
Men aged 65-75 with any lifetime smoking history meet the Grade B recommendation for a one-time abdominal ultrasound.
2
Evaluate the 55-year-old female who is an active heavy smoker.
Identify indication for lung cancer screening.
Adults aged 50-80 with at least a 20 pack-year smoking history require annual screening with low-dose chest computed tomography.
3
Evaluate the 24-year-old female patient.
Identify indication for cervical cancer screening.
Women aged 21-29 require standard screening with cervical cytology (Pap smear) every 3 years.
4
Evaluate the 65-year-old female patient.
Identify indication for osteoporosis screening.
Women aged 65 and older routinely require an initial dual-energy x-ray absorptiometry (DXA) scan to assess bone mineral density.

Key Concept

Age- and risk-appropriate preventive screening guidelines (USPSTF Grade A and B recommendations) for adults in the primary care setting.
Question 1530Question →

Evaluate the following patient presentations from an ambulatory primary care setting. Map each patient's demographic and clinical history to the single most appropriate, evidence-based preventive care intervention required at their current visit.

Click a left item, then click its matching right item

Items

A 28-year-old primigravida at 29 weeks of gestation who received a tetanus booster injection two years prior following a superficial laceration.
A 65-year-old male establishing care. He reports a past habit of smoking one pack of cigarettes daily for 15 years, achieving complete cessation on his fortieth birthday.
A 40-year-old female whose biological mother received a colorectal adenocarcinoma diagnosis at age 46; the patient has no prior lower endoscopic evaluations.
A 55-year-old female who had her uterus and cervix surgically excised a decade ago for symptomatic leiomyomas, with benign surgical pathology.

Matches

Show answer & explanation

Answer

The pregnant patient at 29 weeks requires the Tdap vaccine. The 65-year-old male with a 15 pack-year smoking history requires a one-time AAA screening ultrasound. The 40-year-old female with a high-risk family history of colorectal cancer requires immediate colonoscopy with 5-year intervals. The 55-year-old female post-benign total hysterectomy requires cessation of cervical cancer screening.
Each correct pairing directly reflects current USPSTF and ACIP recommendations. Tdap is mandated in every pregnancy (27-36 weeks). AAA ultrasound is required once for any male 65-75 who has smoked ≥100\geq 100 cigarettes. Colonoscopy begins at age 40 or 10 years before a first-degree relative's early (<60< 60) diagnosis, repeating every 5 years. Total hysterectomy for benign disease is a firm indication to stop cervical cancer screening.

Step-by-Step Solution

1
Evaluate the obstetric patient's immunization status.
Determine that a Tdap booster is indicated.
Guidelines mandate Tdap during every pregnancy between 27-36 weeks to confer passive immunity to the neonate, superseding standard 10-year booster intervals.
2
Analyze the 65-year-old male's smoking history against multiple screening criteria.
Determine that he qualifies for AAA screening but not for lung cancer screening.
He has 'ever smoked' (≥100\geq 100 lifetime cigarettes), satisfying the AAA screening criteria. However, his 15 pack-year history and 25-year cessation interval disqualify him from lung cancer screening (which requires ≥20\geq 20 pack-years and cessation within 15 years).
3
Calculate the indicated start age and interval for colorectal cancer screening in the 40-year-old female.
Determine that screening is past due and requires a 5-year surveillance interval.
A first-degree relative diagnosed at age 46 dictates that screening begin at age 36 (10 years prior to the relative's diagnosis). Because the relative was <60< 60 at diagnosis, the interval is every 5 years.
4
Assess the need for continued cervical cytology in the 55-year-old surgical patient.
Determine that screening should be discontinued.
The patient lacks a cervix and the indication for surgery was benign (leiomyomas), satisfying criteria to safely halt Pap testing.

Key Concept

Application of precise age, exposure, and genetic risk thresholds to select the single most appropriate preventive screening or immunization modality.
Estimated Time:2m 0s
Question 1531Question →

A 58-year-old woman with metastatic ovarian cancer is evaluated during a home hospice visit for a 4-day history of absent bowel movements and worsening lower abdominal discomfort. She has been taking escalating doses of oral morphine for severe pelvic pain over the past two weeks. Arrange the following steps in the correct chronological sequence for the evaluation and stepwise escalation of management for this patient's suspected opioid-induced constipation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Perform an examination to rule out obstruction, 2) Initiate a scheduled stimulant laxative, 3) Add an osmotic laxative, and 4) Administer a peripherally acting mu-opioid receptor antagonist.
The correct sequence prioritizes patient safety by first excluding structural emergencies, followed by a stepwise escalation of pharmacological therapies based on mechanism of action. Mechanical obstruction must be ruled out before any laxatives are given. First-line medical therapy is a stimulant laxative to directly address the underlying opioid-induced hypomotility. If this fails, an osmotic laxative is added for a synergistic effect. Finally, targeted therapy with a PAMORA is reserved for refractory cases due to its specific indication and potential side effect profile.

Step-by-Step Solution

1
Evaluate for contraindications to laxative therapy.
Mechanical bowel obstruction and fecal impaction must be ruled out.
Administering laxatives in the presence of a complete obstruction can lead to severe pain, bowel ischemia, or perforation. This is especially important in patients with a history of intra-abdominal malignancies like ovarian cancer.
2
Initiate first-line pharmacological therapy.
Prescribe a scheduled stimulant laxative (e.g., senna).
Opioids primarily cause constipation by decreasing peristalsis via mu-receptors in the enteric nervous system; stimulant laxatives directly counteract this mechanism and serve as the foundation of therapy.
3
Escalate to combination laxative therapy.
Add an osmotic laxative (e.g., polyethylene glycol).
Dual therapy targeting both motility (stimulant) and stool consistency (osmotic) is the standard next step for persistent opioid-induced constipation.
4
Utilize targeted receptor antagonists for refractory cases.
Administer a PAMORA (e.g., methylnaltrexone).
PAMORAs block peripheral mu-receptors in the gastrointestinal tract without crossing the blood-brain barrier, treating refractory opioid-induced constipation without reversing central analgesia.

Key Concept

Stepwise management of opioid-induced constipation requires excluding mechanical obstruction first, followed by escalating therapy from stimulant laxatives, to combination therapy with osmotic laxatives, and finally to peripherally acting mu-opioid receptor antagonists (PAMORAs).
Estimated Time:1m 0s
Question 1532Question →

For each clinical scenario below, select the most appropriate guideline-concordant preventive screening intervention. Assume patients are asymptomatic and up to date with any age-appropriate interventions not explicitly addressed.

Click a left item, then click its matching right item

Items

Evaluating respiratory health for an asymptomatic 58-year-old man who accumulated 30 pack-years of tobacco exposure before successfully quitting 12 years ago.
Reviewing vascular risks during a welcome-to-Medicare visit for a 68-year-old man; his only tobacco history involves smoking half a pack daily during his four years of college.
Discussing metabolic health with a 43-year-old man who recently gained weight, bringing his body mass index to 33 kg/m².
Addressing cancer surveillance guidelines with a healthy 42-year-old woman possessing a normal body mass index and no family history of malignancy.
Assessing bone health in a 67-year-old woman who has never used tobacco and recently received a normal result on her biennial breast imaging.

Matches

Show answer & explanation

Answer

The correct matches align each patient's specific demographic and risk profile (age, biological sex, BMI, and smoking history) with the corresponding USPSTF Grade B recommendation.
Each combination accurately reflects current USPSTF Grade A and B recommendations. Lung cancer screening requires a 20+ pack-year history and smoking within the last 15 years (target age 50-80). AAA screening requires any lifetime smoking history of at least 100 cigarettes (men 65-75). Diabetes screening is indicated for overweight or obese adults (age 35-70). Mammography begins at age 40. DEXA is universally indicated for women aged 65 and older.

Step-by-Step Solution

1
Analyze tobacco history and age for the male patients.
The 58-year-old has a 30 pack-year history and quit <15 years ago, qualifying for LDCT. The 68-year-old has a remote but positive smoking history (>100 cigarettes), qualifying for an AAA ultrasound.
Lung cancer and AAA screening guidelines are highly specific to age ranges and lifetime tobacco exposure metrics.
2
Evaluate metabolic parameters for the younger male patient.
The 43-year-old has a BMI of 33 (obese), which places him in the screening demographic for diabetes.
Age combined with overweight/obesity triggers glucose screening between ages 35 and 70.
3
Assess the female patients based on age and recent preventive care.
The 42-year-old qualifies for initiation of routine breast cancer screening. The 67-year-old is up to date on mammography but requires baseline osteoporosis screening.
Guidelines require starting mammography at age 40 and DEXA at age 65 for average-risk women.

Key Concept

Application of age-, sex-, and risk-specific USPSTF preventive screening guidelines.
Question 1533Question →

A 40-year-old man presents to the outpatient clinic for a routine health maintenance evaluation. He has no significant past medical history and takes no medications. He has never smoked and consumes alcohol occasionally. He has no history of injection drug use or prior blood transfusions. A review of his records shows that his last lipid panel and HIV screening test were performed 5 years ago and were normal. He has never been screened for hepatitis C virus (HCV) infection. Vital signs are normal. Physical examination is unremarkable, with no scleral icterus or hepatomegaly. Which of the following is the most appropriate recommendation regarding HCV screening for this patient?

Show answer & explanation

Answer: One-time screening with hepatitis C virus antibody testing

Answer

One-time screening with hepatitis C virus antibody testing
The most appropriate next step is one-time screening with hepatitis C virus (HCV) antibody testing. The United States Preventive Services Task Force (USPSTF) recommends one-time universal screening for HCV infection in all adults aged 18 to 79 years, regardless of their risk factors. The initial screening is performed using an HCV antibody test.

Step-by-Step Solution

1
Identify the patient's demographic profile and preventive care needs.
The patient is a 40-year-old man with average risk who has never been screened for hepatitis C virus.
Preventive screening guidelines are heavily dependent on age and prior screening history.
2
Recall the current evidence-based guidelines for hepatitis C virus screening.
The USPSTF recommends universal, one-time screening for hepatitis C virus infection in all adults aged 18 to 79 years.
Applying current guidelines ensures the correct screening intervention is chosen and outdated risk-based practices are avoided.
3
Determine the appropriate initial screening modality.
The initial screening test is the hepatitis C virus antibody test.
Antibody testing is the standard first-step screening tool, followed by confirmatory RNA testing only if the initial result is positive.

Key Concept

The USPSTF recommends one-time screening for hepatitis C virus (HCV) infection with an HCV antibody test for all adults aged 18 to 79 years, regardless of risk factors.
Question 1534Question →

A 62-year-old man with New York Heart Association class II heart failure with reduced ejection fraction is evaluated in the clinic. He is currently treated with lisinopril, metoprolol succinate, and spironolactone. His symptoms have persisted despite maximal tolerated doses of his current regimen. The physician plans to transition the patient from lisinopril to sacubitril-valsartan. His current blood pressure is 118/75 mm Hg, and his heart rate is 68/min. Laboratory studies show a serum potassium of 4.3 mEq/L and a serum creatinine of 1.1 mg/dL. Which of the following are required steps for appropriate treatment adaptation and ongoing monitoring in this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Ensure a minimum 36-hour washout period between the last dose of lisinopril and the first dose of sacubitril-valsartan; Reassess serum potassium and creatinine levels within 1 to 2 weeks after starting the new medication

Answer

The correct steps are ensuring a 36-hour washout period after lisinopril discontinuation and reassessing serum potassium and creatinine within 1 to 2 weeks.
The correct sequence for transitioning a patient from an ACE inhibitor to an angiotensin receptor-neprilysin inhibitor (ARNI) involves two critical safety steps. First, because both ACE inhibitors and neprilysin inhibitors increase bradykinin levels, there is a substantial risk of severe angioedema if they are used simultaneously or in rapid succession. Consequently, guidelines strictly mandate a 36-hour washout period after the final dose of the ACE inhibitor before the first dose of the ARNI. Second, because ARNIs contain an angiotensin II receptor blocker (valsartan), they can precipitate acute kidney injury and hyperkalemia by altering renal efferent arteriolar tone. This risk is further elevated in patients concurrently taking a mineralocorticoid receptor antagonist like spironolactone. Therefore, re-evaluating serum creatinine and potassium levels 1 to 2 weeks after initiation is the standard of care.

Step-by-Step Solution

1
Identify the clinical goal and medication transition.
The patient is being switched from an ACE inhibitor (lisinopril) to an ARNI (sacubitril-valsartan) for symptomatic HFrEF.
Understanding the specific drug classes is essential for recognizing contraindications and required monitoring.
2
Determine the necessary safety precautions for initiation.
A 36-hour washout period is required between stopping the ACE inhibitor and starting the ARNI.
Simultaneous inhibition of ACE and neprilysin leads to excessive bradykinin accumulation, significantly increasing the risk of angioedema.
3
Select appropriate follow-up laboratory monitoring.
Serum potassium and creatinine must be checked 1 to 2 weeks after starting.
The valsartan component can reduce GFR and promote potassium retention, which is compounded by the patient's concurrent spironolactone use.
4
Rule out inappropriate tests and monitoring strategies.
BNP measurement and acute echocardiography are rejected.
Sacubitril inhibits BNP breakdown (making BNP levels falsely high), and acute imaging does not reflect long-term myocardial reverse remodeling.

Key Concept

Transitioning from an ACE inhibitor to an ARNI requires a 36-hour washout to prevent angioedema. Subsequent monitoring must include a basic metabolic panel within 1-2 weeks, and NT-proBNP (not BNP) should be used if biomarker tracking is desired.
Question 1535Question →

An 82-year-old man with a history of New York Heart Association class IV heart failure and severe peripheral artery disease is admitted to the intensive care unit with acute cardiogenic shock. He is currently receiving continuous intravenous infusions of norepinephrine and dobutamine. Despite these interventions, his extremities are cold and mottled, and his urine output is minimal. The attending physician informs the patient that without mechanical circulatory support, such as an intra-aortic balloon pump, he will likely die within hours to days.

The patient is fully alert, oriented to person, place, and time. He accurately repeats the clinical information back to the physician and states, "I have lived a long life and I do not want to spend my final moments hooked up to more machines. Please stop these blood pressure medications and just keep me comfortable."

Shortly after, the patient's adult daughter, who is designated as his legal healthcare proxy in a signed advance directive, arrives at the bedside. She insists that all life-sustaining measures be continued, stating, "He is just overwhelmed right now and not thinking straight. As his healthcare proxy, I authorize the mechanical support."

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Discontinue the vasopressor infusions and administer medications targeted at symptom relief

Answer

Discontinue the vasopressor infusions and administer medications targeted at symptom relief.
The correct answer honors the ethical principle of patient autonomy. This patient has demonstrated clinical decision-making capacity: he understands his diagnosis of cardiogenic shock, appreciates his poor prognosis without mechanical support, and clearly communicates a rational choice to focus on comfort rather than prolonging the dying process. A capacitated adult has the absolute right to refuse any medical intervention. A designated healthcare proxy (such as his daughter) only gains decision-making authority when the patient loses clinical capacity. Therefore, the physician is ethically and legally obligated to respect the patient's wishes, discontinue the unwanted vasopressors, and initiate appropriate palliative symptom management.

Step-by-Step Solution

1
Assess the patient's clinical decision-making capacity.
The patient is alert, oriented, and able to understand, reason, and communicate his choice regarding his terminal prognosis.
Capacity is the foundation of medical decision-making and determines whose consent or refusal is valid.
2
Evaluate the authority of the surrogate decision-maker (the daughter).
The daughter's status as a healthcare proxy is not currently active.
An advance directive and proxy designation only take effect when the primary patient loses clinical decision-making capacity.
3
Implement the capacitated patient's autonomous medical decision.
Vasopressors are discontinued and the focus of care shifts exclusively to comfort measures.
A capacitated adult has the ethical and legal right to refuse any intervention, including life-sustaining treatment, even if the refusal results in death.

Key Concept

A capacitated patient's autonomous refusal of life-sustaining treatment overrides the wishes of family members or designated healthcare proxies. Proxy authority is only invoked when clinical capacity is lost.
Estimated Time:1m 15s
Question 1536Question →

A 74-year-old man is hospitalized with severe aspiration pneumonia. His medical history is significant for progressive amyotrophic lateral sclerosis (ALS) and acute angle-closure glaucoma. He is currently wheelchair-bound and relies on non-invasive positive pressure ventilation for 18 hours daily. Over the past 24 hours, his respiratory status has deteriorated, and he is struggling to clear copious respiratory secretions.

The critical care team explains that without endotracheal intubation, he will likely progress to hypercapnic respiratory failure and die. The patient, communicating clearly via a text-to-speech device, responds: "I understand that I will die without a breathing tube. I have thought about this for months. I want to forgo intubation and antibiotics. Please just keep me comfortable so I can pass away peacefully at home."

His wife, who is his legally designated healthcare proxy, is distraught. She tells the attending physician, "He is just temporarily overwhelmed. You must intubate him and transfer him to the intensive care unit." The physician performs a thorough evaluation and determines that the patient correctly understands his prognosis, appreciates the consequences of his decision, and is reasoning consistently with his long-held values.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Provide symptom-directed palliative therapy and arrange for discharge to home hospice

Answer

Provide symptom-directed palliative therapy and arrange for discharge to home hospice
The correct action is to provide symptom-directed palliative therapy and arrange for discharge to home hospice. The patient has been evaluated by the attending physician and found to possess full clinical decision-making capacity. Because he has capacity, he retains the absolute right to refuse any medical intervention, including life-saving treatments like endotracheal intubation. His autonomous decision legally and ethically overrides the wishes of his wife. Furthermore, discharging him to home hospice directly honors his stated goal of care. Appropriate symptom management must be chosen carefully to avoid contraindications, such as avoiding anticholinergics in the setting of his glaucoma.

Step-by-Step Solution

1
Evaluate the patient's decision-making capacity regarding his medical care.
The physician determined the patient has capacity because he understands his prognosis, the consequences of refusing care, and reasons consistently with his values.
Capacity is required for a patient to autonomously accept or refuse life-sustaining interventions.
2
Determine the legal standing of the healthcare proxy's demands.
The wife's demands cannot be followed.
A healthcare proxy only gains decision-making authority when the primary patient loses clinical capacity. Since the patient retains capacity, his decision supersedes the proxy's.
3
Review the patient's medical history for contraindications to common palliative medications.
The patient has a history of acute angle-closure glaucoma, making anticholinergic agents like scopolamine (often used for respiratory secretions) strictly contraindicated.
Administering contraindicated medications can precipitate a life-threatening crisis, even in palliative settings.
4
Formulate a disposition plan that aligns with the patient's autonomous wishes and medical safety.
The appropriate plan is discharge to home hospice with targeted, safe symptom management.
This directly fulfills the patient's expressed desire to pass away peacefully at home without aggressive interventions.

Key Concept

Clinical Decision-Making Capacity and Palliative Pharmacology
Question 1537Question →

During morning rounds in the medical intensive care unit, a physician evaluates a 74-year-old woman who is being treated for severe community-acquired pneumonia and sepsis. She has a known history of focal impaired awareness seizures, which are normally well-controlled on oral phenytoin. However, due to intubation and enteral feeding intolerance upon admission three days ago, she was transitioned to an intravenous maintenance dose of phenytoin. Today, she has been successfully extubated but appears lethargic and confused. Neurologic examination reveals prominent bilateral horizontal nystagmus, dysarthria, and wide-based truncal ataxia when she is assisted to the edge of the bed.

Morning laboratory results are as follows:

TestResult
Sodium138 mEq/L
Potassium4.1 mEq/L
Blood urea nitrogen18 mg/dL
Creatinine0.9 mg/dL
Albumin2.0 g/dL

A total serum phenytoin concentration obtained two hours prior to the next scheduled dose is 15 mcg/mL (reference range: 10-20 mcg/mL).

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Hold the phenytoin infusion and order a free serum phenytoin level

Answer

Hold the phenytoin infusion and order a free serum phenytoin level.
Phenytoin is a highly protein-bound antiepileptic drug, with approximately 90% typically bound to serum albumin. The standard laboratory assay measures *total* phenytoin, which encompasses both the bound (inactive) and unbound (active, or 'free') fractions. The established normal therapeutic range for total phenytoin is 10-20 mcg/mL. However, in patients with significant hypoalbuminemia (albumin < 3.2 g/dL), such as this critically ill patient, there is a deficit of albumin available for binding. This leads to a substantial increase in the fraction of free, pharmacologically active phenytoin, even when the total level appears normal.

To estimate the true biologically active concentration, the Winter-Tozer equation is applied for patients with normal renal function:
Cadjusted=Ctotal(0.2×Albumin)+0.1C_{adjusted} = \frac{C_{total}}{(0.2 \times \text{Albumin}) + 0.1}

For this patient, the adjusted total phenytoin calculation yields:
Cadjusted=15(0.2×2.0)+0.1=150.4+0.1=150.5=30 mcg/mLC_{adjusted} = \frac{15}{(0.2 \times 2.0) + 0.1} = \frac{15}{0.4 + 0.1} = \frac{15}{0.5} = 30 \text{ mcg/mL}

An adjusted equivalent level of 30 mcg/mL is severely toxic. The patient's clinical presentation of lethargy, prominent bilateral horizontal nystagmus, dysarthria, and truncal ataxia directly reflects acute phenytoin toxicity. Therefore, the most appropriate next step in management is to immediately hold the phenytoin infusion and order a direct free serum phenytoin level (therapeutic range typically 1-2 mcg/mL) to accurately monitor her status and guide future dosing adjustments.

Step-by-Step Solution

1
Evaluate the clinical presentation and neurologic examination.
The patient exhibits lethargy, bilateral horizontal nystagmus, dysarthria, and ataxia.
These findings represent the classic clinical triad of acute phenytoin toxicity.
2
Analyze the laboratory data in the context of the patient's medications.
The total serum phenytoin is 15 mcg/mL (normal range), but the serum albumin is significantly low at 2.0 g/dL.
Phenytoin is highly protein-bound (approximately 90%). Total phenytoin levels measure both bound and unbound fractions. In hypoalbuminemia, there is less protein available, increasing the free, pharmacologically active fraction.
3
Calculate the adjusted total phenytoin level to estimate true toxicity.
Using the Winter-Tozer equation: Adjusted Level = 15 / ((0.2 * 2.0) + 0.1) = 15 / 0.5 = 30 mcg/mL.
An adjusted total level of 30 mcg/mL is well above the therapeutic maximum of 20 mcg/mL, chemically confirming the clinical diagnosis of severe toxicity.
4
Determine the best next step in monitoring and treatment evaluation.
The correct action is to immediately withhold the offending medication and order a direct laboratory measurement of the active component.
Holding the dose prevents further neurotoxicity, and measuring the free phenytoin level (therapeutic range 1-2 mcg/mL) provides an accurate baseline to safely restart and adjust dosing once toxicity resolves.

Key Concept

In patients with significant hypoalbuminemia, highly protein-bound drugs like phenytoin will have a higher free (active) fraction. A standard total phenytoin level may appear falsely normal, necessitating the calculation of an adjusted level or the direct measurement of free phenytoin to avoid and manage toxicity.
Question 1538Question →

A 78-year-old man with a history of severe chronic obstructive pulmonary disease (COPD) and mild cognitive impairment is being prepared for discharge home after receiving treatment for community-acquired pneumonia. He will be returning to live with his daughter. To optimize patient safety and minimize the risk of readmission, arrange the following transitional care and discharge planning steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Assess functional status and caregiver support, 2) Perform discharge medication reconciliation, 3) Schedule a post-discharge follow-up appointment, 4) Counsel the patient and daughter using the teach-back method, and 5) Transmit the discharge summary to the primary care clinic.
A structured, evidence-based discharge process prioritizes patient safety. It begins with confirming the appropriateness of the discharge setting (assessing support). Once the destination is validated, the clinical plan is finalized by reconciling medications. Logistical details, such as follow-up appointments, are then secured so they can be included in the patient's paperwork. Only after the plan and logistics are finalized can the physician effectively educate the patient and family. Finally, the completed plan is transmitted to the outpatient provider to ensure continuity of care.

Step-by-Step Solution

1
Identify the prerequisite step for initiating a safe discharge.
Assessing functional status and caregiver support is selected first.
You cannot formulate a safe discharge plan without first confirming where the patient is going and verifying that they have the necessary support to manage their condition at home.
2
Determine the next clinical action required to finalize the discharge plan.
Medication reconciliation is selected second.
The physician must resolve discrepancies and finalize a safe, accurate medication list before the patient can be educated on their regimen or handed off to outpatient care.
3
Sequence the logistical coordination of outpatient care.
Scheduling the follow-up appointment is placed third.
Appointment dates and times must be secured prior to the final counseling session so this vital information can be communicated verbally and included in the printed discharge paperwork.
4
Sequence the patient and caregiver education.
Counseling using the teach-back method is placed fourth.
Education relies on having the completed medication list and follow-up details ready. Using the teach-back method ensures the patient and caregiver comprehend the finalized plan before leaving the hospital.
5
Identify the final step in the care transition process.
Transmitting the discharge summary is placed last.
The complete summary of the hospital course, reconciled medications, and follow-up arrangements must be sent to the primary care provider to close the communication loop as the transition concludes.

Key Concept

Safe hospital discharge transitions require a systematic, stepwise approach starting with disposition assessment, followed by medication reconciliation, logistical coordination, patient education, and finally, outpatient provider handoff.
Estimated Time:1m 30s
Question 1539Question →

Match each end-of-life clinical scenario to the most appropriate next step in symptom management.

Click a left item, then click its matching right item

Items

A 71-year-old with end-stage idiopathic pulmonary fibrosis who is restless, using accessory muscles, and complaining of severe air hunger despite continuous oxygen therapy.
A 68-year-old with metastatic glioblastoma who is unresponsive in the final days of life, exhibiting coarse, noisy breathing sounds caused by the pooling of oropharyngeal secretions.
A 55-year-old with advanced cervical cancer on high-dose intravenous morphine who develops generalized hyperalgesia, confusion, and frequent myoclonic jerks.
A 64-year-old with an apical lung tumor who experiences paroxysms of severe, electric-shock-like pain radiating down the medial aspect of the left forearm.

Matches

Show answer & explanation

Answer

Refractory dyspnea is managed with systemic low-dose opioids. Terminal secretions are treated with anticholinergic medications. Opioid-induced neurotoxicity requires opioid rotation. Neuropathic pain requires an adjuvant neuromodulating agent.
Optimal end-of-life care relies on accurately matching specific symptoms with their most effective treatments. Low-dose opioids effectively reduce the central perception of dyspnea. Anticholinergic medications dry up pooled oropharyngeal secretions that cause the 'death rattle'. Opioid rotation clears accumulated neurotoxic metabolites while maintaining analgesia. Finally, neuropathic pain requires targeted adjuvant therapy like gabapentinoids.

Step-by-Step Solution

1
Identify the primary symptom causing distress in each patient scenario.
Patient 1 has refractory dyspnea; Patient 2 has terminal secretions; Patient 3 has opioid-induced neurotoxicity; Patient 4 has neuropathic pain.
Accurate symptom identification is the prerequisite for targeted pharmacologic intervention in palliative care.
2
Determine the optimal pharmacologic intervention for each identified symptom based on standard palliative protocols.
Dyspnea is treated with opioids; Secretions with anticholinergics; Neurotoxicity with opioid rotation; Neuropathic pain with neuromodulators.
Targeted therapy maximizes patient comfort and minimizes adverse side effects during end-of-life care.

Key Concept

Palliative pharmacologic symptom management
Question 1540Question →

A 48-year-old woman presents to the clinic for a health maintenance visit. She has a history of type 2 diabetes mellitus, moderate persistent asthma, and obesity. She smoked 1 pack of cigarettes daily for 22 years but quit 5 years ago. She currently feels well and has no acute complaints. Her medications include metformin, atorvastatin, a fluticasone-salmeterol inhaler, and a levonorgestrel-releasing intrauterine device.

A review of her preventive care history reveals the following:
- Screening mammography: Performed 1 year ago (normal, BI-RADS 1)
- Screening colonoscopy: Performed 3 years ago at age 45 (normal)
- Papanicolaou (Pap) test with human papillomavirus (HPV) co-testing: Performed 3 years ago at age 45 (negative)
- Hepatitis C virus antibody test: Performed 2 years ago (negative)
- Tetanus, diphtheria, and pertussis (Tdap) vaccine: Administered 3 years ago
- Influenza vaccine: Received an inactivated influenza vaccine 2 weeks ago

The patient has never received a pneumococcal or zoster vaccine.

Which of the following is the most appropriate next step in preventive care for this patient?

Show answer & explanation

Answer: 20-valent pneumococcal conjugate vaccine

Answer

Administer the 20-valent pneumococcal conjugate vaccine.
The correct intervention is the administration of the 20-valent pneumococcal conjugate vaccine (PCV20). The Advisory Committee on Immunization Practices (ACIP) recommends pneumococcal vaccination for all adults aged 65 and older, as well as for adults aged 19 to 64 years who have certain underlying medical conditions. These conditions include diabetes mellitus, chronic lung disease (such as asthma), chronic heart disease, alcoholism, and immunocompromising conditions. Because this patient is 48 years old and has both diabetes mellitus and asthma, she is at increased risk for invasive pneumococcal disease. She should receive either a single dose of PCV20 or a dose of PCV15 followed by PPSV23. Since she has never received a pneumococcal vaccine, administering PCV20 today is the most appropriate next step.

Step-by-Step Solution

1
Analyze the patient's age and underlying comorbidities.
The patient is 48 years old with type 2 diabetes mellitus and moderate persistent asthma.
Age and specific chronic diseases dictate vaccine and screening eligibility according to ACIP and USPSTF guidelines.
2
Evaluate the patient's eligibility for adult vaccinations.
She is eligible for pneumococcal vaccination due to her diabetes and asthma, but not eligible for the zoster vaccine due to her age (<50) and lack of severe immunocompromise.
ACIP recommends pneumococcal vaccination for all adults aged 19-64 with specific risk factors.
3
Review the patient's eligibility for cancer and osteoporosis screening.
She is up-to-date on breast, cervical, and colorectal cancer screening. She is too young for low-dose chest CT (starts at 50) and DEXA (starts at 65 without high risk).
Verifying exact age and interval cutoffs prevents ordering unnecessary tests or imaging.

Key Concept

Pneumococcal vaccination is indicated for adults aged 19 to 64 years who have specific underlying medical conditions, including diabetes mellitus, chronic lung disease (e.g., asthma, COPD), chronic heart disease, and chronic liver disease.
PreviousPage 77 / 104Next
Patient Management Practice Questions — USMLE Step 3 — Page 77 | Examkin